Elekta AB Company Profile (OTCMKTS:EKTAY)

Analyst Ratings

Consensus Ratings for Elekta AB (OTCMKTS:EKTAY) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Elekta AB (OTCMKTS:EKTAY)
DateFirmActionRatingPrice TargetActions
12/8/2015Morgan StanleyDowngradeEqual Weight -> UnderweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2015Jefferies GroupUpgradeUnderperform -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015DNB MarketsUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2015SwedbankDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015JPMorgan Chase & Co.DowngradeOverweight -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015Goldman Sachs Group Inc.DowngradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2015Citigroup Inc.Initiated CoverageSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2015BNP ParibasDowngradeUnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)


Earnings History for Elekta AB (OTCMKTS:EKTAY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
12/4/2013Q3$0.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)


Earnings Estimates for Elekta AB (OTCMKTS:EKTAY)
No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for Elekta AB (OTCMKTS:EKTAY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Elekta AB (OTCMKTS:EKTAY)
No insider trades for this company have been tracked by MarketBeat.com


Latest Headlines for Elekta AB (OTCMKTS:EKTAY)
07/22/16 08:25 AMElekta AB :EKTAY-US: Earnings Analysis: 2016 By the Numbers : July 22, 2016 -
06/30/16 06:00 AMHealthcare: Stock Selection Increasingly Important -
06/01/16 02:13 AMEuropean shares led down by Sweden's Elekta -
05/24/16 02:05 PMETF’s with exposure to Elekta AB : May 24, 2016 -
05/19/16 03:03 PMElekta AB :EKTAY-US: Earnings Analysis: Q3, 2016 By the Numbers -
05/19/16 08:00 AMElekta Surpasses One Million Patients Treated with Leksell Gamma Knife - [PR Newswire] - At the 18th International Leksell Gamma Knife® Society Meeting in Amsterdam, (May 15-19), Elekta announced that Leksell Gamma Knife, the most clinically-proven radiosurgery system available, has been used in the treatment of more than one million patients afflicted with brain tumors, vascular malformations and functional disorders. Today, Gamma Knife surgery is performed on more than 75,000 patients every year in hundreds of leading hospitals and clinics around the world. "Gamma Knife stereotactic radiosurgery has evolved from a truly disruptive technological innovation to a mainstay of modern radiation surgery and neurosurgery and it has become the most clinically proven and comprehensively studied stereotactic radiosurgery platform in history," said Dr. Laurent Leksell, Elekta's Founder and Chairman of the Board.
05/02/16 06:00 AMNew Data Presented at ESTRO 35 Show Positive Cosmesis and Favorable Late Side Effects After Accelerated Partial Breast Irradiation (APBI) with Multicatheter Interstitial Brachytherapy - [PR Newswire] - TURIN, Italy, May 2, 2016 /PRNewswire/ -- P hase III trial further reinforces treatment as a valid alternative to w hole b reast i rradiation in patients with early breast cancer Clinical equivalence ...
04/29/16 12:30 AMElekta's Latest Monaco Release Features Up to Four Times Faster Calculation Speed for Reduced Radiotherapy Planning Times - [PR Newswire] - TURIN, Italy, April 29, 2016 /PRNewswire/ -- Elekta is pleased to announce that Monaco® version 5.11, the latest update to its industry-leading treatment planning software, is available for clinical release. ...
04/27/16 11:00 AMTransformative Potential of Elekta's High-field MR-guided Linear Accelerator Highlighted in Seven Abstracts at ESTRO 35 - [PR Newswire] - TURIN, Italy, April 27, 2016 /PRNewswire/ -- Elekta today announced that its leading-edge high-field MR-guided linear accelerator (MR-linac) platform will be the focal point of seven scientific presentations ...
04/26/16 12:30 AMMD Anderson Cancer Center to Acquire Elekta Linear Accelerators and Other Radiotherapy Solutions - [PR Newswire] - HOUSTON, Texas, April 26, 2016 /PRNewswire/ -- The University of Texas MD Anderson Cancer Center has signed a deal with Elekta (EKTA-B.ST) to acquire Elekta Infinity™ linear accelerators, brachytherapy ...
04/25/16 12:30 AMElekta to Demonstrate Market-leading Radiosurgery Solutions and Innovations at ESTRO 35 - [PR Newswire] - TURIN, Italy, April 25, 2016 /PRNewswire/ -- ESTRO Booths 200 and 500 - At ESTRO 35 (April 29 - May 3, at Lingotto Fiere in Turin), Elekta will demonstrate a full range of radiotherapy planning and delivery ...
04/22/16 08:00 PMChina's Peking University is Site of 100th Elekta Magnetoencephalography (MEG) System Installed Worldwide - [PR Newswire] - BEIJING, April 23, 2016 /PRNewswire/ -- Cognitive neuroscience researchers at renowned Peking University (Beijing, China) will soon begin using their Elekta Neuromag® TRIUX™ MEG system in a variety of ...
04/18/16 12:30 AMElekta and Philips Begin Installation of MR-Guided Linear Accelerator at The Netherlands Cancer Institute - [PR Newswire] - Elekta (EKTA-B.ST), Royal Philips (NYSE:PHG, AEX:PHIA) and The Netherlands Cancer Institute, (NKI, Amsterdam, The Netherlands) today announced the installation of a high-field (1.5 Tesla) MR-guided linear accelerator (MR-linac) system. The Elekta MR-linac is designed to capture high-quality images of tumors and surrounding tissue, allowing physicians to rapidly assess and respond by modifying the radiation treatment, a responsive intervention approach. The Netherlands Cancer Institute is a member of the Elekta MR-linac Consortium, founded in 2012 by Elekta and technology partner Royal Philips.
04/14/16 08:00 AMOkan University Hospital to Treat Cancer with Elekta Radiation Therapy Equipment - [PR Newswire] - ISTANBUL, April 14, 2016 /PRNewswire/ -- Okan University in Istanbul has recently signed an agreement to acquire Versa HD™ and Elekta Synergy ® linear accelerators (linacs). The equipment will be used ...
04/13/16 12:30 AMRichard Hausmann Appointed as Elekta's President and CEO - [PR Newswire] - STOCKHOLM, April 13, 2016 /PRNewswire/ -- Elekta's (EKTA-B.ST) Board of Directors has appointed Richard Hausmann, to lead the company effective June 10, 2016. He will succeed Tomas Puusepp, current President ...
03/31/16 12:30 AMGenesisCare and Elekta Sign Strategic Partnership for More Than USD 100 Million - [PR Newswire] - STOCKHOLM, March 31, 2016 /PRNewswire/ -- Elekta announced today the formation of a multiyear strategic partnership with GenesisCare, the largest provider of radiotherapy in Australia. The deal, over eight ...
03/22/16 04:00 AMThe Netherlands' Radiotherapy Group is Country's First to Use Elekta's Esteya Electronic Brachytherapy to Treat Skin Cancer Patients - [PR Newswire] - On March 3, Radiotherapy Group clinicians at Ziekenhuis Gelderse Vallei (Ede, the Netherlands) used their Esteya® electronic brachytherapy system for the first time to treat a 73-year-old male patient with a nodular basal cell carcinoma on his nose. Esteya is a form of high dose rate (HDR) brachytherapy that applies high-precision radiotherapy directly to the cancer site, minimizing radiation to surrounding healthy tissues.
03/21/16 05:16 PMETF’s with exposure to Elekta AB : March 21, 2016 -
02/26/16 07:37 AMAt HIMSS16 Meeting, Elekta to Show How Clinicians Can Better Harness Oncology Data With Elekta Healthcare Analytics - [PR Newswire] - LAS VEGAS, February 26, 2016 /PRNewswire/ -- HIMSS Booth #818 - At the Healthcare Information and Management Systems Society's 2016 meeting (HIMSS16), Elekta will showcase Elekta Healthcare Analytics, ...
02/09/16 12:30 AMRussian Clinic Uses Gamma Knife to Treat Record Number of Patients with Brain Cancer and Other Cranial Disorders - [PR Newswire] - Treating three to five patients per day throughout a seven-day work week, the Diagnostic and Treatment Center at the International Institute of Biological Systems is among the most prolific Gamma Knife centers in Eurasia. In 2015, the center treated a record 1,235 patients suffering from brain tumors and other intracranial disorders - 158 in December alone - with the Leksell Gamma Knife® Perfexion™ radiosurgery system it installed in late 2014. The clinic, which began treating with an earlier Gamma Knife model in 2009, has broken its "patients treated" record every year since then.
02/03/16 03:10 PMElekta AB : Undervalued relative to peers, but don’t ignore the other factors -
02/03/16 01:40 PMAnalysis and ELEKTA UNSP ADR EACH REPR 1 ORD (EKTAY) Earnings Review - WallStreet.org - Analysis and ELEKTA UNSP ADR EACH REPR 1 ORD (EKTAY) Earnings ReviewWallStreet.orgWall Street await ELEKTA UNSP ADR EACH REPR 1 ORD (EKTAY) to release earnings on February, 4. It is down 19.45% since June 29, 2015 and is uptrending. It has outperformed by 26.97% the S&P500. ELEKTA UNSP ADR EACH REPR 1 ORD ...and more »
01/21/16 09:30 PMFirst Center in Middle East With Elekta's Versa HD Radiotherapy System Begins Treating Cancer Patients - [PR Newswire] - JEDDAH, Saudi Arabia, January 22, 2016 /PRNewswire/ -- Equipped with advanced beam-shaping and high dose rate delivery technologies, King Abdulaziz University Hospital's (KAUH) Versa HD™ system is enabling ...
12/10/15 11:02 AMElekta AB Earnings Analysis: Q2, 2016 By the Numbers -
12/04/15 02:36 PMElekta AB : Neutral outlook but great fundamentals -
12/01/15 07:55 AMInternationally Renowned Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Acquires Elekta's Leksell Gamma Knife Icon - [PR Newswire] - AMSTERDAM, December 1, 2015 /PRNewswire/ -- The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), among the world's largest and most prestigious cancer centers, has acquired Elekta's ...
11/18/15 08:00 AMElekta Earns Top Rank in 2015's Best in KLAS for Radiation Therapy - [PR Newswire] - ATLANTA, November 18, 2015 /PRNewswire/ -- Elekta took the first place ranking in KLAS's recently released 201 5 Best in KLAS Awards: Medical & Infrastructure report . * KLAS, an independent research firm, ...
11/18/15 12:30 AMAmethyst Radiotherapy Orders Elekta Cancer Treatment Solutions for European Expansion - [PR Newswire] - STOCKHOLM, November 18, 2015 /PRNewswire/ -- Elekta (EKTA-B.ST) will deliver advanced radiotherapy equipment and services to Amethyst Radiotherapy, a private cancer treatment network serving Western and ...
10/26/15 02:30 AMElekta Inaugurates new Radiation Therapy Training Center in South Africa - [PR Newswire] - CAPE TOWN, South Africa, October 26, 2015 /PRNewswire/ -- Elekta inaugurated its advanced Elekta Training Center Cape Town, a collaboration between Elekta and Cape Town's Tygerberg Hospital and Cape Peninsula ...
10/20/15 08:00 AMElekta Raises More Than $28,000 to Support Women With Cancer - [PR Newswire] - SAN ANTONIO, October 20, 2015 /PRNewswire/ -- Elekta activities at the 57th Annual Meeting of the American Society for Radiation Oncology (ASTRO) raised $28,495 for Texas WINGS (Women Involved in Nurturing, ...
10/15/15 08:00 AMAt ASTRO Annual Meeting, Elekta to Highlight Cancer Management Solutions That Advance and Simplify Patient Care - [PR Newswire] - SAN ANTONIO, October 15, 2015 /PRNewswire/ -- At the American Society for Radiation Oncology (ASTRO) Annual Meeting, October 18-21 in San Antonio, Elekta (booth #459) will demonstrate that progress in ...
10/14/15 08:00 AMFlorida's Lynn Cancer Institute Begins Treating Skin Cancer Patients With Elekta's Esteya Electronic Brachytherapy System - [PR Newswire] - With the recent treatment of a 65-year-old woman with a skin cancer lesion on her chin, Lynn Cancer Institute of Boca Raton Regional Hospital launched a new therapy program for patients with basal cell or squamous cell carcinoma of the skin. Esteya® electronic brachytherapy is a form of high dose rate (HDR) brachytherapy that applies high precision radiotherapy directly to the cancer site, minimizing radiation to surrounding tissues and organs. Lynn Cancer Institute is among the first centers in the United States to use Esteya.
10/13/15 12:30 AMInstallation Completed for Elekta MRI-guided linear Accelerator at MD Anderson Cancer Center - [PR Newswire] - HOUSTON, October 13, 2015 /PRNewswire/ -- The University of Texas MD Anderson Cancer Center, Elekta and Philips teams recently completed installation of the first high field (1.5 Tesla) MRI-guided linear ...
10/12/15 12:30 AMSeven US Medical Centers to Acquire Elekta's New Leksell Gamma Knife Icon Brain Radiosurgery System - [PR Newswire] - ATLANTA, October 12, 2015 /PRNewswire/ -- Patients in the United States with brain cancer or any of a range of other neurological disorders will soon have access to the most sophisticated system for the ...
09/25/15 05:00 AMElekta to Showcase New Leksell Gamma Knife Icon at Congress of Neurological Surgeons Annual Meeting - [PR Newswire] - NEW ORLEANS, September 25, 2015 /PRNewswire/ -- Elekta's latest generation intracranial radiosurgery system, Leksell Gamma Knife® Icon™ , will be in the spotlight (booth #336) at the 2015 meeting of the ...
09/02/15 08:00 AMElekta to Host Cancer Survivorship Event at Company's Learning and Innovation Center (LINC) in Atlanta - [PR Newswire] - Elekta, a global cancer management company, will host an educational event on cancer survivorship on September 10, 6:30-8:30 p.m., at Elekta's North American headquarters in Atlanta. "Elekta's Ultimate Ride to Survivorship" will feature Professional BMX athlete, Josh Perry, who will recount his 2012 treatment of a brain tumor with Leksell Gamma Knife®, Elekta's radiosurgery system for treating brain disorders.
08/27/15 08:00 AMNew Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain - [PR Newswire] - ATLANTA, August 27, 2015 /PRNewswire/ -- The Elekta Linac-based Brain Stereotactic Radiation Therapy (SRT) Consortium convened in Boston on July 9th for its inaugural meeting. Elekta created the Consortium ...
08/26/15 12:30 AMUniversity Hospital La Timone World's First To Treat Patients With Leksell Gamma Knife Icon, Elekta's Latest Generation Cranial Radiosurgery System - [PR Newswire] - On August 10, doctors at University Hospital La Timone (Marseilles, France) used their new Leksell Gamma Knife® Icon™ system to treat a metastasis in the brain of a 71-year-old female patient. This single-session treatment was the first time La Timone physicians had harnessed the system's advanced motion management and imaging capabilities to enable therapy using mask-based head fixation instead of the traditional rigid stereotactic frame. With Icon, La Timone physicians are predicting a significant increase in the volume of patients suitable for frameless Gamma Knife radiosurgery.


About Elekta AB

Elekta AB logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: EKTAY
  • CUSIP:
Key Metrics:
  • Previous Close: $7.84
  • 50 Day Moving Average: $7.70
  • 200 Day Moving Average: $7.50
  • P/E Ratio: 186.67
  • P/E Growth: 0.00
  • Market Cap: $2.99B
  • Beta: 0.54
  • Next Year EPS Consensus Estimate: $0.34 EPS
Additional Links:
Elekta AB (OTCMKTS:EKTAY) Chart for Wednesday, July, 27, 2016